top of page
Wilms by the Numbers
  • YouTube
  • Instagram
  • Facebook
  • LinkedIn
  • Twitter
  • TikTok
  • Pinterest
20200701_153627.jpg

Key Facts

Wilms (or ‘nephroblastoma’) is the most common type of kidney cancer in children.

 

About 1 in 10,000 diagnosed with the disease each year in North America. Overall around 7,500 children under the age of 18 suffer from Wilms at any given time and about 190,000 worldwide.

 

Often beginning in the womb with the tumour growing on the kidney with the most common symptom being a sudden swollen stomach. Eventually the tumor becomes much bigger than the kidney itself and both usually require removal. Later stage Wilms can spread to other parts of the body including the lungs, liver and bones.

Statistics

4

of all childhood cancers are Wilms (3)

7,500

children with Wilms in North America per yr. (8)

low survival rate 'diffuse anaplastic' Wilms (10)

30-45%

$833,000

$700

14.6%

medical bankruptcies (childhood illness) (14) 

Note: Figures presented based on mean averages.

th

most common childhood cancer (2)

5/100

9/10

of all childhood kidney cancers are Wilms (4)

1/10,000

children are at risk from Wilms (5)

600-700

new cases of Wilms in North America per yr. (6)

55%

diagnosed with Wilms after it has spread (7)

190,000

children suffer Wilms worldwide per yr. (9)

$100

cost of early detection of Wilms (one-time) (11)

late detection treatment cost (per yr.) (12)

more per day to treat children with cancer (13)

Global Snap-Shot

pngwing.com.png

Bolivia

New cases: N/A

In-treatment: N/A

Mortality rate/s: 29%

Nigeria

New cases: N/A

In-treatment: N/A

Mortality rate/s: 67%

Malawi

New cases: N/A

In-treatment: N/A

Mortality rate/s: 54%

India

New cases: 1,600

In-treatment: N/A

Mortality rate/s: 34%

Australia

New cases: 23

In-treatment: N/A

Mortality rate/s: 7%

China

New cases: N/A

In-treatment: N/A

Mortality rate/s: 24%

By Country

Germany

New cases: N/A

In-treatment: N/A

Mortality rate/s: 7%

UK

New cases: N/A

In-treatment: N/A

Mortality rate/s: 7%

Canada

New cases: 70-80

In-treatment: N/A

Mortality rate/s: 7%

USA

New cases: 600-700

In-treatment: N/A

Mortality rate/s: 7%

Equador

New cases: N/A

In-Treatment: N/A

Mortality rate/s: 24%

Alphabetical Order

Australia

New cases: 23

In-treatment: N/A

Mortality rate/s: 7%

Argentina

New cases: N/A

In-treatment: N/A

Mortality rate/s: N/A

Austria

New cases: 36

In-treatment: N/A

Mortality rate/s: 7%

Belgium

New cases: 80

In-treatment: N/A

Mortality rate/s: 7%

Brazil

New cases: 332

In-treatment: N/A

Mortality rate/s: N/A

Bolivia

New cases: N/A

In-treatment: N/A

Mortality rate/s: 29%

Canada

New cases: 70-80

In-treatment: N/A

Mortality rate/s: 7%

China

New cases: N/A

In-treatment: N/A

Mortality rate/s: 24%

Croatia

New cases: 4

In-treatment: N/A

Mortality rate/s: N/A

Czech Republic

New cases: 5

In-treatment: N/A

Mortality rate/s: 7%

Denmark

New cases: 38

In-treatment: N/A

Mortality rate/s: 7%

Egypt

New cases: N/A

In-treatment: N/A

Mortality rate/s: 8%

Equador

New cases: N/A

In-treatment: N/A

Mortality rate/s: 24%

France

New cases: 687

In-treatment: N/A

Mortality rate/s: 7%

Germany

New cases: 695

In-treatment: N/A

Mortality rate/s: 7%

Greece

New cases: 23

In-treatment: N/A

Mortality rate/s: 7%

Holland

New cases: 164

In-treatment: N/A

Mortality rate/s: 7%

India

New cases: 1,600

In-treatment: N/A

Mortality rate/s: 34%

Iran

New cases: N/A

In-treatment: N/A

Mortality rate/s: 28%

Iraq

New cases: N/A

In-treatment: N/A

Mortality rate/s: 27%

Italy

New cases: 61

In-treatment: N/A

Mortality rate/s: 7%

Kenya

New cases: N/A

In-treatment: N/A

Mortality rate/s: 33%

Malawi

New cases: N/A

In-treatment: N/A

Mortality rate/s: 54%

Mexico

New cases: N/A

In-treatment: N/A

Mortality rate/s: N/A

Norway

New cases: 22

In-treatment: N/A

Mortality rate/s: 7%

New Zealand

New cases: 4

In-treatment: N/A

Mortality rate/s: 7%

Nigeria

New cases: N/A

In-treatment: N/A

Mortality rate/s: 67%

Peru

New cases: N/A

In-treatment: N/A

Mortality rate/s: 29%

Poland

New cases: N/A

In-treatment: N/A

Mortality rate/s: 7%

Republic of Ireland

New cases: 28

In-treatment: N/A

Mortality rate/s: 7%

Serbia & Montenegro

New cases: 7

In-treatment: N/A

Mortality rate/s: 7%

Slovak Republic

New cases: 26

In-treatment: N/A

Mortality rate/s: 7%

Slovenia

New cases: 22

In-treatment: N/A

Mortality rate/s: 7%

South Africa

New cases: N/A

In-treatment: N/A

Mortality rate/s: 30%

Spain

New cases: 156

In-treatment: N/A

Mortality rate/s: 7%

Sweden

New cases: 92

In-treatment: N/A

Mortality rate/s: 7%

Switzerland

New cases: 55

In-treatment: N/A

Mortality rate/s: 7%

Uganda

New cases: N/A

In-treatment: N/A

Mortality rate/s: 30%

UK

New cases: 561

In-treatment: N/A

Mortality rate/s: 7%

USA

New cases: 600-700

In-treatment: N/A

Mortality rate/s: 7%

bottom of page